Liver Citrate Anticoagulation Threshold study
ISRCTN | ISRCTN92716512 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN92716512 |
Secondary identifying numbers | CVVHD- Ci-Ca-01-EU |
- Submission date
- 26/08/2008
- Registration date
- 04/12/2008
- Last edited
- 30/09/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Stanislao Morgera
Scientific
Scientific
Universitätskrankenhaus Charité
Medizinische Klinik - Nephrologie
Berlin
10117
Germany
Study information
Study design | Prospective observational open multi-centre study |
---|---|
Primary study design | Observational |
Secondary study design | |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Citrate anticoagulation during continuous veno-venous haemodialysis (CVVHD) - an observational study |
Study acronym | LCAT study |
Study objectives | 1. Assessment of the safety and efficacy of regional citrate anticoagulation during continuous veno-venous haemodialysis (CVVHD) using multiFiltrate with the Ci-Ca System® 2. Investigation of the impact of liver failure on safety, efficacy and dosing schemes of this procedure |
Ethics approval(s) | Ethics Committee of Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin), 27/07/2007, ref: EA1/101/07 |
Health condition(s) or problem(s) studied | Intensive care patients with renal failure |
Intervention | Every patient will be observed for 72 hours after the start of the Ci-Ca CVVHD treatment. The participation in the study and the data collection will be terminated before 72 hours if the patient does not require a Ci-Ca CVVHD treatment any more. |
Intervention type | Other |
Primary outcome measure | Main end-points for the safety evaluation is the occurrence of citrate metabolic complications (hypocalcemia, hypercalcemia, alkalosis, acidosis). For the efficacy evaluation main end-points are: the percentage of functioning filters after 72 treatment hours and post-filter ionized calcium. |
Secondary outcome measures | No secondary outcome measures |
Overall study start date | 07/12/2007 |
Completion date | 31/12/2009 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 120 |
Key inclusion criteria | 1. Adult patients (at least 18 years old, both males and females) treated on intensive care unit (ICU) due to renal failure requiring CVVHD and citrate anticoagulation (treatment with the multiFiltrate Ci-Ca System®) 2. Patient (or his legal representative or the next of kin - according to the local requirements) written informed consent |
Key exclusion criteria | 1. Use of regional citrate anticoagulation in the period of 72 hours preceding the enrolment in the study 2. Concomitant participation in another clinical trial 3. Previous participation in the same study |
Date of first enrolment | 07/12/2007 |
Date of final enrolment | 31/12/2009 |
Locations
Countries of recruitment
- Austria
- Germany
- Norway
- Switzerland
- United Kingdom
Study participating centre
Universitätskrankenhaus Charité
Berlin
10117
Germany
10117
Germany
Sponsor information
Fresenius Medical Care (Germany)
Industry
Industry
Else-Kröner-Str. 1
Bad Homburg
61352
Germany
Website | http://www.fmc-ag.com |
---|---|
https://ror.org/04sk0bj73 |
Funders
Funder type
Industry
Fresenius Medical Care (Germany)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/02/2011 | Yes | No | |
Results article | results | 29/09/2015 | Yes | No |